nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Bicalutamide—prostate cancer	0.044	0.505	CbGbCtD
Quinidine barbiturate—CYP2D6—Abiraterone—prostate cancer	0.0365	0.418	CbGbCtD
Quinidine barbiturate—KCNK1—prostate gland—prostate cancer	0.00805	0.133	CbGeAlD
Quinidine barbiturate—KCNK1—seminal vesicle—prostate cancer	0.00681	0.113	CbGeAlD
Quinidine barbiturate—CYP2D6—Doxorubicin—prostate cancer	0.00674	0.0773	CbGbCtD
Quinidine barbiturate—KCNK1—renal system—prostate cancer	0.00548	0.0908	CbGeAlD
Quinidine barbiturate—KCNK1—urethra—prostate cancer	0.00539	0.0892	CbGeAlD
Quinidine barbiturate—CYP2D6—urine—prostate cancer	0.00502	0.0831	CbGeAlD
Quinidine barbiturate—CHRM2—prostate gland—prostate cancer	0.00409	0.0677	CbGeAlD
Quinidine barbiturate—KCNK1—testis—prostate cancer	0.00354	0.0587	CbGeAlD
Quinidine barbiturate—KCNH2—prostate gland—prostate cancer	0.00296	0.0489	CbGeAlD
Quinidine barbiturate—GRIA2—testis—prostate cancer	0.00289	0.0477	CbGeAlD
Quinidine barbiturate—KCNK1—lymph node—prostate cancer	0.00257	0.0425	CbGeAlD
Quinidine barbiturate—KCNH2—seminal vesicle—prostate cancer	0.0025	0.0414	CbGeAlD
Quinidine barbiturate—Quinine—SLC22A1—prostate cancer	0.00218	0.121	CrCbGaD
Quinidine barbiturate—KCNH2—renal system—prostate cancer	0.00201	0.0333	CbGeAlD
Quinidine barbiturate—KCNH2—urethra—prostate cancer	0.00198	0.0327	CbGeAlD
Quinidine barbiturate—Quinidine—SLC22A1—prostate cancer	0.00191	0.106	CrCbGaD
Quinidine barbiturate—Quinine—CYP3A5—prostate cancer	0.00176	0.0974	CrCbGaD
Quinidine barbiturate—KCNH2—bone marrow—prostate cancer	0.00152	0.0252	CbGeAlD
Quinidine barbiturate—GABRA2—lymph node—prostate cancer	0.00136	0.0225	CbGeAlD
Quinidine barbiturate—KCNH2—testis—prostate cancer	0.0013	0.0215	CbGeAlD
Quinidine barbiturate—CYP2D6—renal system—prostate cancer	0.00123	0.0203	CbGeAlD
Quinidine barbiturate—Quinine—CYP2E1—prostate cancer	0.00121	0.067	CrCbGaD
Quinidine barbiturate—Quinine—CYP2C19—prostate cancer	0.0012	0.0663	CrCbGaD
Quinidine barbiturate—Quinine—CYP1A1—prostate cancer	0.00119	0.0661	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2C18—prostate cancer	0.00106	0.0589	CrCbGaD
Quinidine barbiturate—Quinidine—CYP2E1—prostate cancer	0.00106	0.0589	CrCbGaD
Quinidine barbiturate—Quinidine—CYP1A1—prostate cancer	0.00105	0.0581	CrCbGaD
Quinidine barbiturate—KCNH2—lymph node—prostate cancer	0.000944	0.0156	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP1B1—prostate cancer	0.000878	0.0487	CrCbGaD
Quinidine barbiturate—CYP2D6—testis—prostate cancer	0.000794	0.0131	CbGeAlD
Quinidine barbiturate—Quinine—CYP3A4—prostate cancer	0.00076	0.0422	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP3A5—prostate cancer	0.000699	0.0388	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2A6—prostate cancer	0.000677	0.0375	CrCbGaD
Quinidine barbiturate—Quinidine—CYP3A4—prostate cancer	0.000668	0.0371	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2E1—prostate cancer	0.000481	0.0267	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2C19—prostate cancer	0.000476	0.0264	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP1A1—prostate cancer	0.000474	0.0263	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP3A4—prostate cancer	0.000303	0.0168	CrCbGaD
Quinidine barbiturate—Thrombocytopenia—Docetaxel—prostate cancer	0.000182	0.000279	CcSEcCtD
Quinidine barbiturate—Rash—Estradiol—prostate cancer	0.000182	0.000279	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—prostate cancer	0.000181	0.000279	CcSEcCtD
Quinidine barbiturate—Dermatitis—Estradiol—prostate cancer	0.000181	0.000278	CcSEcCtD
Quinidine barbiturate—Confusional state—Capecitabine—prostate cancer	0.000181	0.000278	CcSEcCtD
Quinidine barbiturate—Tachycardia—Docetaxel—prostate cancer	0.000181	0.000278	CcSEcCtD
Quinidine barbiturate—Headache—Estradiol—prostate cancer	0.00018	0.000277	CcSEcCtD
Quinidine barbiturate—Skin disorder—Docetaxel—prostate cancer	0.00018	0.000277	CcSEcCtD
Quinidine barbiturate—Agitation—Prednisone—prostate cancer	0.00018	0.000276	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.00018	0.000276	CcSEcCtD
Quinidine barbiturate—Oedema—Capecitabine—prostate cancer	0.00018	0.000276	CcSEcCtD
Quinidine barbiturate—Bradycardia—Epirubicin—prostate cancer	0.000179	0.000275	CcSEcCtD
Quinidine barbiturate—Angioedema—Prednisone—prostate cancer	0.000179	0.000275	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—prostate cancer	0.000178	0.000274	CcSEcCtD
Quinidine barbiturate—Urticaria—Etoposide—prostate cancer	0.000177	0.000272	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Epirubicin—prostate cancer	0.000177	0.000272	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—prostate cancer	0.000177	0.000272	CcSEcCtD
Quinidine barbiturate—Anorexia—Docetaxel—prostate cancer	0.000177	0.000271	CcSEcCtD
Quinidine barbiturate—Shock—Capecitabine—prostate cancer	0.000177	0.000271	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Etoposide—prostate cancer	0.000176	0.000271	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Etoposide—prostate cancer	0.000176	0.000271	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Capecitabine—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Vertigo—Prednisone—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Epirubicin—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Hepatitis—Epirubicin—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Capecitabine—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Syncope—Prednisone—prostate cancer	0.000176	0.00027	CcSEcCtD
Quinidine barbiturate—Tachycardia—Capecitabine—prostate cancer	0.000175	0.000269	CcSEcCtD
Quinidine barbiturate—Skin disorder—Capecitabine—prostate cancer	0.000174	0.000268	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—prostate cancer	0.000174	0.000267	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Epirubicin—prostate cancer	0.000174	0.000267	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Capecitabine—prostate cancer	0.000174	0.000266	CcSEcCtD
Quinidine barbiturate—Hypotension—Docetaxel—prostate cancer	0.000173	0.000266	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Epirubicin—prostate cancer	0.000173	0.000265	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Prednisone—prostate cancer	0.000172	0.000264	CcSEcCtD
Quinidine barbiturate—Anorexia—Capecitabine—prostate cancer	0.000171	0.000263	CcSEcCtD
Quinidine barbiturate—Nausea—Estradiol—prostate cancer	0.000171	0.000263	CcSEcCtD
Quinidine barbiturate—Vomiting—Mitoxantrone—prostate cancer	0.000171	0.000262	CcSEcCtD
Quinidine barbiturate—Convulsion—Prednisone—prostate cancer	0.00017	0.000261	CcSEcCtD
Quinidine barbiturate—Visual impairment—Epirubicin—prostate cancer	0.00017	0.00026	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—prostate cancer	0.000169	0.00026	CcSEcCtD
Quinidine barbiturate—Rash—Mitoxantrone—prostate cancer	0.000169	0.00026	CcSEcCtD
Quinidine barbiturate—Dermatitis—Mitoxantrone—prostate cancer	0.000169	0.000259	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000169	0.000259	CcSEcCtD
Quinidine barbiturate—Headache—Mitoxantrone—prostate cancer	0.000168	0.000258	CcSEcCtD
Quinidine barbiturate—Hypotension—Capecitabine—prostate cancer	0.000168	0.000258	CcSEcCtD
Quinidine barbiturate—Myalgia—Prednisone—prostate cancer	0.000167	0.000256	CcSEcCtD
Quinidine barbiturate—Arthralgia—Prednisone—prostate cancer	0.000167	0.000256	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Epirubicin—prostate cancer	0.000166	0.000256	CcSEcCtD
Quinidine barbiturate—Anxiety—Prednisone—prostate cancer	0.000166	0.000255	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—prostate cancer	0.000166	0.000255	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000166	0.000254	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Docetaxel—prostate cancer	0.000165	0.000254	CcSEcCtD
Quinidine barbiturate—Somnolence—Docetaxel—prostate cancer	0.000165	0.000253	CcSEcCtD
Quinidine barbiturate—Eye disorder—Epirubicin—prostate cancer	0.000165	0.000253	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Etoposide—prostate cancer	0.000164	0.000252	CcSEcCtD
Quinidine barbiturate—Tinnitus—Epirubicin—prostate cancer	0.000164	0.000252	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—prostate cancer	0.000164	0.000251	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000164	0.000251	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—prostate cancer	0.000163	0.000251	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—prostate cancer	0.000163	0.000251	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—prostate cancer	0.000163	0.00025	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—prostate cancer	0.000163	0.00025	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Docetaxel—prostate cancer	0.000161	0.000248	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—prostate cancer	0.000161	0.000247	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00016	0.000246	CcSEcCtD
Quinidine barbiturate—Asthenia—Etoposide—prostate cancer	0.00016	0.000246	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Capecitabine—prostate cancer	0.00016	0.000246	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisone—prostate cancer	0.00016	0.000246	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—prostate cancer	0.00016	0.000245	CcSEcCtD
Quinidine barbiturate—Nausea—Mitoxantrone—prostate cancer	0.000159	0.000245	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Epirubicin—prostate cancer	0.000159	0.000244	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—prostate cancer	0.000159	0.000244	CcSEcCtD
Quinidine barbiturate—Pain—Docetaxel—prostate cancer	0.000159	0.000243	CcSEcCtD
Quinidine barbiturate—Constipation—Docetaxel—prostate cancer	0.000159	0.000243	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—prostate cancer	0.000158	0.000243	CcSEcCtD
Quinidine barbiturate—Pruritus—Etoposide—prostate cancer	0.000158	0.000242	CcSEcCtD
Quinidine barbiturate—Shock—Prednisone—prostate cancer	0.000157	0.000242	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—prostate cancer	0.000157	0.000241	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Prednisone—prostate cancer	0.000157	0.000241	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisone—prostate cancer	0.000156	0.00024	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Capecitabine—prostate cancer	0.000156	0.00024	CcSEcCtD
Quinidine barbiturate—Skin disorder—Prednisone—prostate cancer	0.000155	0.000239	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000155	0.000238	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisone—prostate cancer	0.000155	0.000237	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—prostate cancer	0.000154	0.000237	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—prostate cancer	0.000154	0.000236	CcSEcCtD
Quinidine barbiturate—Constipation—Capecitabine—prostate cancer	0.000154	0.000236	CcSEcCtD
Quinidine barbiturate—Pain—Capecitabine—prostate cancer	0.000154	0.000236	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—prostate cancer	0.000153	0.000235	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—prostate cancer	0.000153	0.000235	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Docetaxel—prostate cancer	0.000153	0.000235	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Etoposide—prostate cancer	0.000153	0.000234	CcSEcCtD
Quinidine barbiturate—Anorexia—Prednisone—prostate cancer	0.000152	0.000234	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—prostate cancer	0.000152	0.000234	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—prostate cancer	0.000152	0.000233	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Docetaxel—prostate cancer	0.000152	0.000233	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—prostate cancer	0.000151	0.000232	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—prostate cancer	0.000151	0.000232	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—prostate cancer	0.00015	0.000231	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—prostate cancer	0.000149	0.000229	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Capecitabine—prostate cancer	0.000148	0.000227	CcSEcCtD
Quinidine barbiturate—Dizziness—Etoposide—prostate cancer	0.000148	0.000227	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—prostate cancer	0.000147	0.000226	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Capecitabine—prostate cancer	0.000147	0.000225	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—prostate cancer	0.000147	0.000225	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Docetaxel—prostate cancer	0.000147	0.000225	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Docetaxel—prostate cancer	0.000147	0.000225	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—prostate cancer	0.000146	0.000224	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000146	0.000224	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—prostate cancer	0.000144	0.000222	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—prostate cancer	0.000143	0.000219	CcSEcCtD
Quinidine barbiturate—Urticaria—Capecitabine—prostate cancer	0.000143	0.000219	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Capecitabine—prostate cancer	0.000142	0.000218	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Capecitabine—prostate cancer	0.000142	0.000218	CcSEcCtD
Quinidine barbiturate—Vomiting—Etoposide—prostate cancer	0.000142	0.000218	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—prostate cancer	0.000142	0.000218	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—prostate cancer	0.000142	0.000218	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—prostate cancer	0.000141	0.000216	CcSEcCtD
Quinidine barbiturate—Rash—Etoposide—prostate cancer	0.000141	0.000216	CcSEcCtD
Quinidine barbiturate—Dermatitis—Etoposide—prostate cancer	0.000141	0.000216	CcSEcCtD
Quinidine barbiturate—Headache—Etoposide—prostate cancer	0.00014	0.000215	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—prostate cancer	0.000139	0.000214	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Prednisone—prostate cancer	0.000139	0.000213	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—prostate cancer	0.000138	0.000211	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—prostate cancer	0.000138	0.000211	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—prostate cancer	0.000137	0.000211	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—prostate cancer	0.000137	0.000211	CcSEcCtD
Quinidine barbiturate—Constipation—Prednisone—prostate cancer	0.000137	0.00021	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Docetaxel—prostate cancer	0.000137	0.00021	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—prostate cancer	0.000135	0.000208	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—prostate cancer	0.000135	0.000207	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—prostate cancer	0.000134	0.000205	CcSEcCtD
Quinidine barbiturate—Asthenia—Docetaxel—prostate cancer	0.000133	0.000204	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—prostate cancer	0.000133	0.000204	CcSEcCtD
Quinidine barbiturate—Nausea—Etoposide—prostate cancer	0.000133	0.000203	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Capecitabine—prostate cancer	0.000132	0.000203	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Prednisone—prostate cancer	0.000132	0.000202	CcSEcCtD
Quinidine barbiturate—Pruritus—Docetaxel—prostate cancer	0.000131	0.000201	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Prednisone—prostate cancer	0.000131	0.000201	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—prostate cancer	0.00013	0.0002	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—prostate cancer	0.00013	0.0002	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—prostate cancer	0.00013	0.0002	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—prostate cancer	0.00013	0.0002	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—prostate cancer	0.00013	0.0002	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.00013	0.000199	CcSEcCtD
Quinidine barbiturate—Asthenia—Capecitabine—prostate cancer	0.000129	0.000198	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—prostate cancer	0.000127	0.000196	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—prostate cancer	0.000127	0.000195	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisone—prostate cancer	0.000127	0.000195	CcSEcCtD
Quinidine barbiturate—Pruritus—Capecitabine—prostate cancer	0.000127	0.000195	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—prostate cancer	0.000127	0.000195	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Docetaxel—prostate cancer	0.000127	0.000195	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Prednisone—prostate cancer	0.000126	0.000194	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Prednisone—prostate cancer	0.000126	0.000194	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—prostate cancer	0.000126	0.000194	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—prostate cancer	0.000125	0.000192	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—prostate cancer	0.000125	0.000192	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—prostate cancer	0.000125	0.000191	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—prostate cancer	0.000123	0.000189	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—prostate cancer	0.000123	0.000189	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Capecitabine—prostate cancer	0.000123	0.000189	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—prostate cancer	0.000123	0.000188	CcSEcCtD
Quinidine barbiturate—Dizziness—Docetaxel—prostate cancer	0.000123	0.000188	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—prostate cancer	0.000122	0.000188	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—prostate cancer	0.000122	0.000187	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—prostate cancer	0.000122	0.000187	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—prostate cancer	0.000121	0.000186	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—prostate cancer	0.000121	0.000185	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—prostate cancer	0.000121	0.000185	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—prostate cancer	0.000121	0.000185	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—prostate cancer	0.00012	0.000185	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00012	0.000184	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—prostate cancer	0.000119	0.000183	CcSEcCtD
Quinidine barbiturate—Dizziness—Capecitabine—prostate cancer	0.000119	0.000182	CcSEcCtD
Quinidine barbiturate—Vomiting—Docetaxel—prostate cancer	0.000118	0.000181	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisone—prostate cancer	0.000118	0.000181	CcSEcCtD
Quinidine barbiturate—Rash—Docetaxel—prostate cancer	0.000117	0.00018	CcSEcCtD
Quinidine barbiturate—Hypotension—Epirubicin—prostate cancer	0.000117	0.000179	CcSEcCtD
Quinidine barbiturate—Dermatitis—Docetaxel—prostate cancer	0.000117	0.000179	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—prostate cancer	0.000117	0.000179	CcSEcCtD
Quinidine barbiturate—Headache—Docetaxel—prostate cancer	0.000116	0.000178	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—prostate cancer	0.000116	0.000178	CcSEcCtD
Quinidine barbiturate—Asthenia—Prednisone—prostate cancer	0.000115	0.000176	CcSEcCtD
Quinidine barbiturate—Vomiting—Capecitabine—prostate cancer	0.000114	0.000175	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000114	0.000175	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—prostate cancer	0.000114	0.000175	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—prostate cancer	0.000114	0.000174	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—prostate cancer	0.000113	0.000174	CcSEcCtD
Quinidine barbiturate—Rash—Capecitabine—prostate cancer	0.000113	0.000174	CcSEcCtD
Quinidine barbiturate—Pruritus—Prednisone—prostate cancer	0.000113	0.000174	CcSEcCtD
Quinidine barbiturate—Dermatitis—Capecitabine—prostate cancer	0.000113	0.000174	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—prostate cancer	0.000113	0.000173	CcSEcCtD
Quinidine barbiturate—Headache—Capecitabine—prostate cancer	0.000112	0.000173	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—prostate cancer	0.000112	0.000173	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—prostate cancer	0.000112	0.000172	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—prostate cancer	0.000112	0.000171	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—prostate cancer	0.000111	0.000171	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—prostate cancer	0.00011	0.000169	CcSEcCtD
Quinidine barbiturate—Nausea—Docetaxel—prostate cancer	0.00011	0.000169	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Prednisone—prostate cancer	0.000109	0.000168	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—prostate cancer	0.000109	0.000167	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—prostate cancer	0.000108	0.000166	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000108	0.000166	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—prostate cancer	0.000107	0.000164	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—prostate cancer	0.000107	0.000164	CcSEcCtD
Quinidine barbiturate—Nausea—Capecitabine—prostate cancer	0.000107	0.000164	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisone—prostate cancer	0.000106	0.000162	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000105	0.000162	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Doxorubicin—prostate cancer	0.000103	0.000158	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—prostate cancer	0.000103	0.000158	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—prostate cancer	0.000103	0.000158	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000102	0.000157	CcSEcCtD
Quinidine barbiturate—Vomiting—Prednisone—prostate cancer	0.000102	0.000156	CcSEcCtD
Quinidine barbiturate—Rash—Prednisone—prostate cancer	0.000101	0.000155	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisone—prostate cancer	0.000101	0.000155	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—prostate cancer	0.000101	0.000154	CcSEcCtD
Quinidine barbiturate—Headache—Prednisone—prostate cancer	0.0001	0.000154	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.99e-05	0.000153	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—prostate cancer	9.94e-05	0.000153	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—prostate cancer	9.9e-05	0.000152	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—prostate cancer	9.9e-05	0.000152	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—prostate cancer	9.89e-05	0.000152	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—prostate cancer	9.89e-05	0.000152	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—prostate cancer	9.54e-05	0.000146	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisone—prostate cancer	9.5e-05	0.000146	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—prostate cancer	9.47e-05	0.000145	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Epirubicin—prostate cancer	9.22e-05	0.000141	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—prostate cancer	9.2e-05	0.000141	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—prostate cancer	9.15e-05	0.00014	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—prostate cancer	9.15e-05	0.00014	CcSEcCtD
Quinidine barbiturate—Asthenia—Epirubicin—prostate cancer	8.98e-05	0.000138	CcSEcCtD
Quinidine barbiturate—Pruritus—Epirubicin—prostate cancer	8.85e-05	0.000136	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Epirubicin—prostate cancer	8.56e-05	0.000131	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—prostate cancer	8.53e-05	0.000131	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—prostate cancer	8.3e-05	0.000127	CcSEcCtD
Quinidine barbiturate—Dizziness—Epirubicin—prostate cancer	8.27e-05	0.000127	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—prostate cancer	8.19e-05	0.000126	CcSEcCtD
Quinidine barbiturate—Vomiting—Epirubicin—prostate cancer	7.95e-05	0.000122	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—prostate cancer	7.92e-05	0.000122	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—prostate cancer	7.89e-05	0.000121	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—prostate cancer	7.88e-05	0.000121	CcSEcCtD
Quinidine barbiturate—Headache—Epirubicin—prostate cancer	7.84e-05	0.00012	CcSEcCtD
Quinidine barbiturate—Dizziness—Doxorubicin—prostate cancer	7.65e-05	0.000118	CcSEcCtD
Quinidine barbiturate—Nausea—Epirubicin—prostate cancer	7.43e-05	0.000114	CcSEcCtD
Quinidine barbiturate—Vomiting—Doxorubicin—prostate cancer	7.36e-05	0.000113	CcSEcCtD
Quinidine barbiturate—Rash—Doxorubicin—prostate cancer	7.3e-05	0.000112	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—prostate cancer	7.29e-05	0.000112	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—prostate cancer	7.25e-05	0.000111	CcSEcCtD
Quinidine barbiturate—Nausea—Doxorubicin—prostate cancer	6.88e-05	0.000106	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—prostate cancer	5.31e-05	0.00029	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGT2B15—prostate cancer	5.15e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGT2B17—prostate cancer	5.15e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CKMT2—prostate cancer	5.15e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GRHPR—prostate cancer	5.15e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNG5—prostate cancer	5.13e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—prostate cancer	5.13e-05	0.00028	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	5.11e-05	0.000279	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—prostate cancer	5.1e-05	0.000279	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—prostate cancer	5.06e-05	0.000277	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—prostate cancer	4.96e-05	0.000271	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTHLH—prostate cancer	4.92e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.87e-05	0.000266	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SULT2B1—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RFK—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AOX1—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PGAM2—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM3—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAGLU—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MBTPS1—prostate cancer	4.85e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WNT4—prostate cancer	4.82e-05	0.000263	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUP—prostate cancer	4.82e-05	0.000263	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—prostate cancer	4.71e-05	0.000257	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—prostate cancer	4.68e-05	0.000256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ANXA1—prostate cancer	4.63e-05	0.000253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MC2R—prostate cancer	4.6e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RALBP1—prostate cancer	4.6e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SRD5A2—prostate cancer	4.59e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AMACR—prostate cancer	4.59e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAT1—prostate cancer	4.59e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP3A43—prostate cancer	4.59e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DEGS1—prostate cancer	4.59e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SRC—prostate cancer	4.58e-05	0.00025	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.53e-05	0.000248	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTHLH—prostate cancer	4.47e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—prostate cancer	4.46e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—prostate cancer	4.41e-05	0.000241	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B1—prostate cancer	4.38e-05	0.00024	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKACB—prostate cancer	4.38e-05	0.000239	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CALCA—prostate cancer	4.33e-05	0.000237	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—prostate cancer	4.32e-05	0.000236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP3CA—prostate cancer	4.27e-05	0.000233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL12—prostate cancer	4.23e-05	0.000231	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ANXA1—prostate cancer	4.2e-05	0.00023	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PENK—prostate cancer	4.1e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—prostate cancer	4.09e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	4.08e-05	0.000223	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—prostate cancer	4.01e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—prostate cancer	4e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CALCA—prostate cancer	3.94e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GHR—prostate cancer	3.91e-05	0.000214	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HPGD—prostate cancer	3.91e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—B4GALT4—prostate cancer	3.91e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.87e-05	0.000211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCQ—prostate cancer	3.86e-05	0.000211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL12—prostate cancer	3.84e-05	0.00021	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—prostate cancer	3.79e-05	0.000207	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRP1—prostate cancer	3.75e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TNFRSF21—prostate cancer	3.67e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRB2—prostate cancer	3.63e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP7B1—prostate cancer	3.57e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTAP—prostate cancer	3.57e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—VAV3—prostate cancer	3.54e-05	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCQ—prostate cancer	3.51e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNRH1—prostate cancer	3.49e-05	0.000191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VIP—prostate cancer	3.49e-05	0.000191	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SULT1E1—prostate cancer	3.48e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SRD5A1—prostate cancer	3.48e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ITPR1—prostate cancer	3.44e-05	0.000188	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPAR1—prostate cancer	3.38e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRP—prostate cancer	3.38e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLCB2—prostate cancer	3.34e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LRP2—prostate cancer	3.34e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B3—prostate cancer	3.32e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACSL4—prostate cancer	3.32e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	3.3e-05	0.00018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	3.28e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—P4HB—prostate cancer	3.28e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—VAV3—prostate cancer	3.22e-05	0.000176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	3.22e-05	0.000176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRB7—prostate cancer	3.19e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDE4D—prostate cancer	3.19e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PHGDH—prostate cancer	3.18e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UMPS—prostate cancer	3.18e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ARG2—prostate cancer	3.18e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LDHB—prostate cancer	3.12e-05	0.000171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	3.12e-05	0.000171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	3.11e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	3.1e-05	0.00017	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—prostate cancer	3.08e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP3A5—prostate cancer	3.06e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNG5—prostate cancer	3.03e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UCP3—prostate cancer	2.96e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TCN2—prostate cancer	2.96e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA3—prostate cancer	2.96e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PDHA1—prostate cancer	2.96e-05	0.000162	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—prostate cancer	2.84e-05	0.000155	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC22A3—prostate cancer	2.82e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD3B1—prostate cancer	2.82e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA4—prostate cancer	2.71e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TBXAS1—prostate cancer	2.71e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTHLH—prostate cancer	2.64e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	2.64e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA2—prostate cancer	2.64e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG5—prostate cancer	2.61e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SULT1A1—prostate cancer	2.61e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	2.6e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKACB—prostate cancer	2.58e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA1—prostate cancer	2.55e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	2.52e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—THBS1—prostate cancer	2.52e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD3B2—prostate cancer	2.52e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTO1—prostate cancer	2.52e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAT2—prostate cancer	2.52e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ANXA1—prostate cancer	2.48e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	2.44e-05	0.000133	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LRP2—prostate cancer	2.41e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLCB2—prostate cancer	2.41e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2C18—prostate cancer	2.41e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	2.38e-05	0.00013	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—P4HB—prostate cancer	2.37e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGFR4—prostate cancer	2.35e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PARP1—prostate cancer	2.35e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CALCA—prostate cancer	2.33e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC22A1—prostate cancer	2.3e-05	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL12—prostate cancer	2.27e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SULT2A1—prostate cancer	2.24e-05	0.000123	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MED12—prostate cancer	2.21e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNG5—prostate cancer	2.19e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	2.16e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP9—prostate cancer	2.14e-05	0.000117	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA3—prostate cancer	2.11e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	2.09e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	2.07e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGFR—prostate cancer	2.07e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	2.05e-05	0.000112	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HPGDS—prostate cancer	2.01e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2C19—prostate cancer	2e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF10—prostate cancer	1.97e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—prostate cancer	1.95e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACHE—prostate cancer	1.95e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRB2—prostate cancer	1.95e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.93e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	1.92e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	1.91e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	1.9e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VAV3—prostate cancer	1.9e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.88e-05	0.000103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	1.87e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRKACB—prostate cancer	1.87e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.85e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITPR1—prostate cancer	1.84e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	1.83e-05	9.98e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—prostate cancer	1.76e-05	9.63e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA2—prostate cancer	1.76e-05	9.62e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	1.75e-05	9.59e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—JAK2—prostate cancer	1.75e-05	9.54e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPL—prostate cancer	1.69e-05	9.24e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.68e-05	9.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—prostate cancer	1.68e-05	9.16e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	1.67e-05	9.15e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	1.66e-05	9.06e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.64e-05	8.96e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITGB3—prostate cancer	1.63e-05	8.92e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NQO1—prostate cancer	1.62e-05	8.86e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TH—prostate cancer	1.6e-05	8.74e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	1.59e-05	8.71e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB3—prostate cancer	1.58e-05	8.65e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.58e-05	8.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGFR2—prostate cancer	1.58e-05	8.64e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.55e-05	8.5e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—prostate cancer	1.52e-05	8.32e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—prostate cancer	1.52e-05	8.29e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GGT1—prostate cancer	1.51e-05	8.23e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA1—prostate cancer	1.48e-05	8.11e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.46e-05	7.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.45e-05	7.93e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEP—prostate cancer	1.42e-05	7.74e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RXRA—prostate cancer	1.41e-05	7.71e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.4e-05	7.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—prostate cancer	1.39e-05	7.58e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—prostate cancer	1.36e-05	7.43e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—prostate cancer	1.35e-05	7.39e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.35e-05	7.39e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ITPR1—prostate cancer	1.33e-05	7.27e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BAD—prostate cancer	1.32e-05	7.21e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.28e-05	6.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—prostate cancer	1.28e-05	6.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGF—prostate cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TYMS—prostate cancer	1.26e-05	6.87e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—prostate cancer	1.24e-05	6.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.23e-05	6.7e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPL—prostate cancer	1.22e-05	6.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—prostate cancer	1.21e-05	6.61e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.19e-05	6.48e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.18e-05	6.44e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.17e-05	6.4e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ERCC2—prostate cancer	1.17e-05	6.39e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.16e-05	6.37e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.13e-05	6.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.12e-05	6.14e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.11e-05	6.08e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.11e-05	6.07e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.1e-05	6.01e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—prostate cancer	1.1e-05	6e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARA—prostate cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.08e-05	5.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.06e-05	5.8e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.03e-05	5.64e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAV1—prostate cancer	1.01e-05	5.54e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.01e-05	5.52e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.01e-05	5.5e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—prostate cancer	9.92e-06	5.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	9.79e-06	5.35e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—prostate cancer	9.41e-06	5.14e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—prostate cancer	9.23e-06	5.04e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	9.19e-06	5.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	9.09e-06	4.97e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—prostate cancer	9.01e-06	4.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—prostate cancer	8.99e-06	4.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—prostate cancer	8.95e-06	4.89e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—prostate cancer	8.77e-06	4.79e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—prostate cancer	8.74e-06	4.78e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	8.68e-06	4.75e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CREBBP—prostate cancer	8.56e-06	4.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—prostate cancer	8.51e-06	4.65e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	8.48e-06	4.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—prostate cancer	8.46e-06	4.63e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—prostate cancer	8.26e-06	4.51e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.11e-06	4.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—prostate cancer	8.07e-06	4.41e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SRC—prostate cancer	7.85e-06	4.29e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—prostate cancer	7.66e-06	4.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—prostate cancer	7.64e-06	4.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—prostate cancer	7.57e-06	4.14e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.07e-06	3.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—prostate cancer	7.03e-06	3.84e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—prostate cancer	7.02e-06	3.83e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—prostate cancer	7.01e-06	3.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—prostate cancer	6.88e-06	3.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—prostate cancer	6.5e-06	3.55e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—prostate cancer	6.11e-06	3.34e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	5.97e-06	3.26e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—prostate cancer	5.83e-06	3.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—prostate cancer	5.78e-06	3.16e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—prostate cancer	5.29e-06	2.89e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—prostate cancer	4.88e-06	2.67e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.31e-06	2.36e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—prostate cancer	3.52e-06	1.93e-05	CbGpPWpGaD
